Compliance Rate
Compliance Rate
66.67%
Compliant submissions
2
Incompliant submissions
1
Total trials
3
My Organizations' Clinical Trials
Showing 250 of 458 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/31/07
End: 05/31/13
Due: 05/31/14
Phase: N/A
Priority: Normal
Start: 11/30/04
End: 11/30/06
Due: 11/30/07
Phase: N/A
Priority: Normal
Start: 02/28/07
End: 10/31/07
Due: 10/31/08
Phase: N/A
Priority: Normal
Start: 05/01/13
End: 03/29/17
Due: 03/29/18
ACTHAR for Acute Treatment of Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate
Phase: N/A
Priority: Normal
Start: 06/23/14
End: 09/01/16
Due: 09/01/17
Phase: N/A
Priority: Normal
Start: 02/28/14
End: 06/30/16
Due: 06/30/17
Phase: N/A
Priority: Normal
Start: 12/07/19
End: 03/31/23
Due: 03/31/24
Phase: N/A
Priority: Normal
Start: 05/24/18
End: 04/05/21
Due: 04/05/22
Phase: N/A
Priority: Normal
Start: 06/16/17
End: 09/01/20
Due: 09/01/21
Phase: N/A
Priority: Normal
Start: 04/02/25
End: 06/30/27
Due: 06/30/28
Phase: N/A
Priority: Normal
Start: 07/31/13
End: 11/30/13
Due: 11/30/14
Phase: N/A
Priority: Normal
Start: 09/07/17
End: 03/31/20
Due: 03/31/21
Phase: N/A
Priority: Normal
Start: 02/01/04
End: 06/24/22
Due: 06/24/23
Phase: N/A
Priority: Normal
Start: 04/30/09
End: 03/09/18
Due: 03/09/19
Phase: N/A
Priority: Normal
Start: 09/30/07
End: 01/31/11
Due: 01/31/12
Phase: N/A
Priority: Normal
Start: 10/31/12
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 05/31/07
End: 09/30/09
Due: 09/30/10
Phase: N/A
Priority: Normal
Start: 04/30/14
End: 07/31/16
Due: 07/31/17
Phase: N/A
Priority: Normal
Start: 09/20/15
End: 05/31/17
Due: 05/31/18
Phase: N/A
Priority: Normal
Start: 05/18/24
End: 12/02/25
Due: 12/02/26
Phase: N/A
Priority: Normal
Start: 02/01/20
End: 06/30/23
Due: 06/30/24
Phase: N/A
Priority: Normal
Start: 12/01/23
End: 06/01/27
Due: 06/01/28
Phase: N/A
Priority: Normal
Start: 06/30/11
End: 02/29/12
Due: 02/28/13
Phase: N/A
Priority: Normal
Start: 08/31/14
End: 03/31/16
Due: 03/31/17
Phase: N/A
Priority: Normal
Start: 10/31/10
End: 04/01/21
Due: 04/01/22